Sun Pharmaceutical Hits Day Low of Rs. 1547.25 Amid Price Pressure

Sun Pharmaceutical Industries has experienced a notable decline today, with the stock dropping by 3.31% as of September 26, 2025. The company reached a new 52-week low of Rs 1547.25, marking a significant intraday low of Rs 1547.25, which reflects a decrease of 4.96% from the previous close. The stock opened with a gap down of 2.3%, indicating a challenging start to the trading session.
In terms of volatility, Sun Pharmaceutical has shown high fluctuations today, with an intraday volatility of 37.74%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a downward trend in its performance metrics.

Comparatively, Sun Pharmaceutical's performance has underperformed against the broader market, with a 1-day decline of 3.10% versus the Sensex's decrease of 0.40%. Over the past week, the stock has fallen by 4.74%, while the Sensex has seen a smaller decline of 2.17%. This trend continues over longer periods, with the stock down 16.90% over the past year compared to the Sensex's 5.83% decline.